Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
暂无分享,去创建一个
Daniel Wolff | Anita Lawitschka | E. Holler | H. Greinix | Stephanie J. Lee | S. Pavletic | Stephanie J Lee | Steven Z Pavletic | O. Grauer | A. Lawitschka | Ernst Holler | H. Bertz | I. Kleiter | D. Wolff | Hildegard Greinix | Hartmut Bertz | Oliver Grauer | Jörn-Sven Kühl | Ingo Kleiter | J. Kühl
[1] C. Dittrich. Planung und Durchführung klinischer Phase-II-Studien , 2008, Oncology Research and Treatment.
[2] S. Bowyer,et al. Steroid myopathy: incidence and detection in a population with asthma. , 1985, The Journal of allergy and clinical immunology.
[3] T. Goodship,et al. Immune complex glomerulonephritis, myasthenia gravis and compensated hypothyroidism in a patient following allogeneic bone marrow transplantation. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[4] C. Mackall,et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. , 2005, The Journal of clinical investigation.
[5] J. Meulstee,et al. Cytomegalovirus infection and Guillain-Barre syndrome , 1996, Neurology.
[6] D. Couriel. Ancillary and supportive care in chronic graft-versus-host disease. , 2008, Best practice & research. Clinical haematology.
[7] S. Chevret,et al. Plasma exchange for myasthenia gravis. , 2002, The Cochrane database of systematic reviews.
[8] D. Mulrooney,et al. Late occurrence of chronic immune-mediated axonal polyneuropathy following bone marrow transplant for juvenile-onset α-mannosidosis , 2003, Bone Marrow Transplantation.
[9] W. Whitehouse,et al. Management of children with Guillain-Barré syndrome , 2007, Archives of Disease in Childhood - Education and Practice.
[10] L. Moreland. Primary angiitis of the central nervous system , 2004 .
[11] B. George,et al. Polymyositis – an unusual manifestation of chronic graft-versus-host disease , 2001, Rheumatology International.
[12] L. Becker,et al. Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease , 1999, Bone Marrow Transplantation.
[13] J. Mackey,et al. Myasthenia gravis post allogeneic bone marrow transplantation revisited , 1998, Bone Marrow Transplantation.
[14] Gherardi,et al. Dermatomyositis‐like graft‐versus‐host disease , 1998, The British journal of dermatology.
[15] Timothy A. Miller,et al. Muscle cramps , 2005, Muscle & nerve.
[16] D. Min,et al. Prevention of graft-versus-host disease by anti IL-7Ralpha antibody. , 2007, Blood.
[17] C. Hawkins,et al. Angiography-negative primary central nervous system vasculitis in children: a newly recognized inflammatory central nervous system disease. , 2005, Arthritis and rheumatism.
[18] F. Miller,et al. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies , 2000, The Lancet.
[19] B. Leber,et al. Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis. , 1993, Bone marrow transplantation.
[20] B. Radovancević,et al. GUILLAIN-BARRE SYNDROME AFTER SOLID ORGAN TRANSPLANTATION , 2001, Transplantation.
[21] C. Chang,et al. Central nervous system graft-versus-host disease: report of two cases and literature review , 2007, Bone Marrow Transplantation.
[22] H. Vinters,et al. NEUROPATHOLOGIC FINDINGS AFTER BONE MARROW TRANSPLANTATION: AN AUTOPSY STUDY 113 , 1987 .
[23] Y. Ikeda,et al. Recurrent Acute Myositis after Allogeneic Bone Marrow Transplantation for Myelodysplasia , 2002, Hematology.
[24] M. Mcquillen,et al. Neurologic complications of graft-versus-host disease. , 1988, Neurologic clinics.
[25] D. Douek,et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients , 2005, The Journal of experimental medicine.
[26] M. Bromberg,et al. Consensus statement: The use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the aanem AD HOC committee , 2009, Muscle & nerve.
[27] T. Starzl,et al. Sensorimotor neuropathy resembling CIDP in patients receiving FK506 , 1994, Muscle & nerve.
[28] P. Wen,et al. Guillain-Barré syndrome following allogeneic bone marrow transplantation , 1997, Neurology.
[29] S. Chevret,et al. Plasma exchange for generalised myasthenia gravis , 2002 .
[30] J. Nabholtz,et al. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature , 1997, Bone Marrow Transplantation.
[31] M. Mohty,et al. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[32] M. Tanimoto,et al. Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. , 2007, Blood.
[33] M. Perales,et al. Rituximab-responsive Guillain–Barré syndrome following allogeneic hematopoietic SCT , 2008, Bone Marrow Transplantation.
[34] J. Briones,et al. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[35] S. Al‐Mayouf,et al. Efficacy of Early Treatment of Severe Juvenile Dermatomyositis with Intravenous Methylprednisolone and Methotrexate , 2000, Clinical Rheumatology.
[36] E. Holler,et al. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[37] W. Engel,et al. Assessment: Symptomatic Treatment for Muscle Cramps (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of The American Academy of Neurology , 2010, Neurology.
[38] J. Owczarek,et al. Drug-induced myopathies. An overview of the possible mechanisms. , 2005, Pharmacological reports : PR.
[39] H. Yoshikawa,et al. [Chronic inflammatory demyelinating polyradiculoneuropathy and hyponatremia in a patient with chronic graft versus host disease]. , 2008, Rinsho shinkeigaku = Clinical neurology.
[40] L. H. van den Berg,et al. The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy , 1999, Neurology.
[41] Y. Shoenfeld,et al. Autoimmune diseases and autoimmunity post-bone marrow transplantation , 1998, Bone Marrow Transplantation.
[42] M. Harada,et al. Myositis as a manifestation of chronic graft-versus-host disease. , 2000, Internal medicine.
[43] M. Tanimoto,et al. Clonal expansion of limited T cell clonotypes in affected muscle from a patient with post-transplant polymyositis , 2002, Bone Marrow Transplantation.
[44] S. Chevret,et al. Intravenous immunoglobulin for myasthenia gravis. , 2012, The Cochrane database of systematic reviews.
[45] M. Kami,et al. Early central nervous system complications after reduced-intensity stem cell transplantation. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[46] C. Mok,et al. Rituximab for refractory polymyositis: an open-label prospective study. , 2007, The Journal of rheumatology.
[47] R. Hughes,et al. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection , 1999, Journal of neurology, neurosurgery, and psychiatry.
[48] A. Straube,et al. Angiitis of the central nervous system after allogeneic bone marrow transplantation? , 1999, Stroke.
[49] K. Bulsara,et al. GUILLAIN-BARRE SYNDROME IN ORGAN AND BONE MARROW TRANSPLANT PATIENTS , 2001, Transplantation.
[50] T. Sharshar,et al. Immunosuppressant drugs for myasthenia gravis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[51] A. Straube,et al. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation , 2003, Neurology.
[52] P. Wen,et al. Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] A. Stevens. Foreign cells in polymyositis: Could stem cell transplantation and pregnancy-derived chimerism lead to the same disease? , 2003, Current rheumatology reports.
[54] D. Ježek,et al. CNS angiitis in graft vs host disease , 2002, Neurology.
[55] A. Amato,et al. Muscle‐specific kinase (MuSK) antibody‐associated myasthenia gravis after bone marrow transplantation , 2008, Muscle & nerve.
[56] M. Turner,et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[57] M. Kiernan,et al. Guillain-Barré syndrome: An update , 2009, Journal of Clinical Neuroscience.
[58] R. Hughes. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial , 2009, Expert review of neurotherapeutics.
[59] K. Sullivan,et al. Myasthenia gravis after allogeneic bone marrow transplantation , 1986, Neurology.
[60] R. Fanin,et al. Myasthenia gravis after allogeneic bone marrow transplantation: a case report. , 1995, Bone marrow transplantation.
[61] A. Straube,et al. Cerebral angiitis in four patients with chronic GVHD , 2010, Bone Marrow Transplantation.
[62] R. Gruber,et al. Graft-versus-host disease in the central nervous system. A real entity? , 1988, American journal of clinical pathology.
[63] S. Forman,et al. Immune-mediated myelopathy after allogeneic marrow transplantation. , 1995, Bone marrow transplantation.
[64] D. Sanders,et al. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity , 2009, The Lancet Neurology.
[65] W. M. Smit,et al. α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease , 2004 .
[66] P. Bouche,et al. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[67] B. Stamford. What Are Muscle Cramps? , 1986, The Physician and sportsmedicine.
[68] Kenneth G. C. Smith,et al. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. , 2009, Arthritis and rheumatism.
[69] D. Isenberg,et al. Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathy. , 2008, Clinical and experimental rheumatology.
[70] B. Sadzot,et al. Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation , 1998, Bone Marrow Transplantation.
[71] R. Hughes,et al. Guillain-Barré syndrome. , 1994, Lancet.
[72] R. D. de Haan,et al. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy , 1998, Journal of neurology, neurosurgery, and psychiatry.
[73] J. G. Quintrec,et al. Drug-induced myopathies. , 1991, Bailliere's clinical rheumatology.
[74] Rachel L. Mistur,et al. Graft-Versus-Host Disease , 2016 .
[75] J. Campbell,et al. Cerebral vasculitis in graft-versus-host disease: a case report. , 2005, AJNR. American journal of neuroradiology.
[76] C. Nakaseko,et al. Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT , 2009, Bone Marrow Transplantation.
[77] A. Reed,et al. Chimerism in children with juvenile dermatomyositis , 2000, The Lancet.
[78] B. Feldman,et al. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood , 2008, The Lancet.
[79] Y. Nevo,et al. Childhood acute and chronic immune-mediated polyradiculoneuropathies. , 2009, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[80] J. Meulstee,et al. Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group. , 1996, Neurology.
[81] D. Couriel,et al. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation , 2002, Bone Marrow Transplantation.
[82] H. Heslop,et al. Guillain–Barré syndrome after allogeneic hematopoietic stem cell transplantation , 2002, Bone Marrow Transplantation.
[83] A. Grañena,et al. Inflammatory myopathy associated with chronic graft‐ versus‐host disease , 1986, Neurology.
[84] L. Hammarström,et al. Autoantibody formation after bone marrow transplantation. Comparison between acetylcholine receptor antibodies and other autoantibodies and analysis of HLA and Gm markers. , 1989, European neurology.
[85] R. Schneider,et al. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. , 2005, Arthritis and rheumatism.
[86] Paul J. Martin,et al. Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. , 2008, The Keio journal of medicine.
[87] H. Teive,et al. Chronic inflammatory demyelinating polyradiculoneuropathy in chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: case report. , 2007, Arquivos de neuro-psiquiatria.
[88] P. Thomas,et al. Successful treatment of refractory generalized myasthenia gravis with rituximab , 2009, European journal of neurology.
[89] Stephanie J. Lee,et al. Transplantation's greatest challenges: advances in chronic graft-versus-host disease. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[90] S. Emerson,et al. CD4+ T Cells Generated De Novo from Donor Hemopoietic Stem Cells Mediate the Evolution from Acute to Chronic Graft-versus-Host Disease1 , 2007, The Journal of Immunology.
[91] Wu Mj,et al. Antibodies against the acetylcholine receptor in hematologic disorders: implications for the development of myasthenia gravis after bone marrow grafting. , 1987 .
[92] J. Mendell,et al. Polyneuropathy complicating bone marrow and solid organ transplantation , 1993, Neurology.
[93] R. Hughes,et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline * on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society , 2005, Journal of the peripheral nervous system : JPNS.
[94] B. Zweiman,et al. Guillain‐Barré syndrome and Hodgkin's disease: Three cases with immunological studies , 1977, Annals of neurology.
[95] Steven A Greenberg,et al. Inflammatory myopathies: disease mechanisms , 2009, Current opinion in neurology.
[96] W. M. Smit,et al. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[97] J. Lipton,et al. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[98] A. Clark,et al. Neuroinflammation and demyelination in multiple sclerosis after allogeneic hematopoietic stem cell transplantation. , 2010, Archives of neurology.
[99] T. Chao,et al. Polymyositis complicating donor lymphocyte infusion after stem cell transplantation for relapsed chronic myeloid leukemia: report of a case and review of literature , 2007, Clinical Rheumatology.
[100] M. Dalakas. The role of high-dose immune globulin intravenous in the treatment of dermatomyositis. , 2006, International immunopharmacology.
[101] M. Minegishi,et al. Subacute panencephalitis associated with chronic graft-versus-host disease , 2004, Acta Neuropathologica.
[102] A. Mauskop. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. , 2018, Neurology.
[103] E. Wijdicks,et al. Acute neuropathies after peripheral blood stem cell and bone marrow transplantation , 2003, Muscle & nerve.
[104] W. Peters,et al. Guillain‐Barre Syndrome Following Autologous Bone Marrow Transplantation , 1995, American journal of clinical oncology.
[105] M. Pagala,et al. Lifetime course of myasthenia gravis , 2008, Muscle & nerve.
[106] A. Uccelli,et al. Central and peripheral nervous system complications following allogeneic bone marrow transplantation , 2001, European journal of neurology.
[107] M. Flowers,et al. Chronic graft-versus-host disease. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[108] C. Marosi,et al. Fatal encephalitis in a patient with chronic graft-versus-host disease. , 1990, Bone marrow transplantation.
[109] Jeanette M Dowell,et al. Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma , 1999, Bone Marrow Transplantation.
[110] N. Kamata,et al. Immune-Mediated Myelopathy following Allogeneic Stem Cell Transplantation , 2006, International journal of hematology.
[111] S. Perkins,et al. Histogenetic phenotypes of B cells in posttransplant lymphoproliferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantation. , 2005, American journal of clinical pathology.
[112] J. Winn,et al. Brain , 1878, The Lancet.
[113] J. Road,et al. Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness , 2001, Thorax.
[114] W. Au,et al. Immunological and electrophysiological investigations of severe ptosis after bone marrow transplantation , 2004, Bone Marrow Transplantation.
[115] S. Pavletic,et al. Chronic Graft versus Host Disease: Interdisciplinary Management: Contents , 2009 .
[116] E. Montgomery,et al. Graft-versus-host-like disease complicating thymoma: lack of AIRE expression as a cause of non-hereditary autoimmunity? , 2007, Immunology letters.
[117] K. Akashi,et al. Encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation. , 2009, Internal medicine.
[118] A. Rojiani,et al. Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature , 2007, Bone Marrow Transplantation.
[119] K. Sullivan,et al. Polymyositis as a manifestation of chronic graft-versus-host disease. , 2003, Rheumatology.
[120] A. Nademanee,et al. Polymyositis as a Manifestation of Chronic Graft‐Versus‐Host Disease , 1996, Medicine.
[121] B. Scheithauer,et al. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. , 2010, Brain : a journal of neurology.
[122] T. Maisonobe,et al. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. , 2002, Arthritis and rheumatism.
[123] D. Saperstein. Chronic acquired demyelinating polyneuropathies. , 2008, Seminars in neurology.
[124] D. Min,et al. Prevention of graft-versus-host disease by anti–IL-7Rα antibody , 2007 .
[125] Chen Liu,et al. Impaired thymic negative selection causes autoimmune graft-versus-host disease. , 2003, Blood.
[126] P. Bierman,et al. Exacerbation of inflammatory demyelinating polyneuropathy after bone marrow transplantation. , 1991, Bone Marrow Transplantation.
[127] R. Hughes,et al. Guillain-Barré syndrome , 1994, The Lancet.
[128] Po-min Chen,et al. Acute polymyositis after donor lymphocyte infusion , 2005, European journal of haematology.
[129] A. Toubert,et al. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. , 2009, Blood.
[130] G. Pizzolato,et al. Cerebral vasculitis during FK 506 treatment in a liver transplant patient , 1998, Neurology.
[131] D. Annane,et al. Immunotherapy for Guillain-Barré syndrome: a systematic review. , 2007, Brain : a journal of neurology.
[132] J. Shortt,et al. Central nervous system graft‐versus‐host disease post allogeneic stem cell transplant , 2006, British journal of haematology.
[133] A. Straube,et al. Cerebral involvement in graft-versus-host disease after murine bone marrow transplantation , 2001, Neurology.
[134] L. Gerber,et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[135] M. Tormo,et al. Guillain–Barré syndrome associated with cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation , 2005, Transplant infectious disease : an official journal of the Transplantation Society.
[136] Je-Jung Lee,et al. Polymyositis and myocarditis after donor lymphocyte infusion , 2009, International journal of hematology.
[137] H. Openshaw. Chronic Graft versus Host Disease: Interdisciplinary Management: Neurological Manifestations of Chronic Graft versus Host Disease , 2009 .
[138] W. Seeley,et al. Post-transplant acute limbic encephalitis , 2007, Neurology.
[139] R. Hohlfeld,et al. Corticosteroids for myasthenia gravis. , 2005, The Cochrane database of systematic reviews.
[140] J. Ritz,et al. Rituximab for steroid-refractory chronic graft-versus-host disease. , 2006, Blood.
[141] B. Zweiman,et al. Guillain-Barré syndrome and Hodgkin's disease: three cases with immunologic studies. , 1975, Transactions of the American Neurological Association.
[142] P Woo,et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. , 2004, Rheumatology.
[143] T. Brannagan. Current treatments of chronic immune‐mediated demyelinating polyneuropathies , 2009, Muscle & nerve.
[144] A. Straube,et al. Neurological and neuroradiological findings in long‐term survivors of allogeneic bone marrow transplantation , 1998, Annals of neurology.
[145] S. Forman,et al. Myositis associated with graft-versus-host disease. , 1997, Current opinion in rheumatology.
[146] J. Elbers,et al. Central nervous system vasculitis in children. , 2008, Current opinion in rheumatology.